In reply to Li et al. Letter to the editor. “Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): a meta-analysis of randomized clinical trials.”. [Carta] (2022)
- Authors:
- Autor USP: ARRUDA, GUSTAVO VIANI - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.radonc.2022.09.017
- Subjects: NEOPLASIAS PULMONARES; NEOPLASIAS PULMONARES; ENSAIO CLÍNICO; DOSAGEM DE RADIAÇÃO
- Language: Inglês
- Imprenta:
- Source:
- Título: Radiotherapy and Oncology
- ISSN: 0167-8140
- Volume/Número/Paginação/Ano: v. 177, p. 245-246, 2022
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
ARRUDA, Gustavo Viani e GOUVEIA, Andre G. e MORAES, Fabio Y. In reply to Li et al. Letter to the editor. “Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): a meta-analysis of randomized clinical trials.”. [Carta]. Radiotherapy and Oncology. Clare: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.radonc.2022.09.017. Acesso em: 01 jan. 2026. , 2022 -
APA
Arruda, G. V., Gouveia, A. G., & Moraes, F. Y. (2022). In reply to Li et al. Letter to the editor. “Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): a meta-analysis of randomized clinical trials.”. [Carta]. Radiotherapy and Oncology. Clare: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.radonc.2022.09.017 -
NLM
Arruda GV, Gouveia AG, Moraes FY. In reply to Li et al. Letter to the editor. “Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): a meta-analysis of randomized clinical trials.”. [Carta] [Internet]. Radiotherapy and Oncology. 2022 ; 177 245-246.[citado 2026 jan. 01 ] Available from: https://doi.org/10.1016/j.radonc.2022.09.017 -
Vancouver
Arruda GV, Gouveia AG, Moraes FY. In reply to Li et al. Letter to the editor. “Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): a meta-analysis of randomized clinical trials.”. [Carta] [Internet]. Radiotherapy and Oncology. 2022 ; 177 245-246.[citado 2026 jan. 01 ] Available from: https://doi.org/10.1016/j.radonc.2022.09.017 - Cost-effectiveness analysis comparing intensity-modulated radiotherapy with conformational radiotherapy (3D-RT) for prostate cancer in the brazilian health system
- Stereotactic body radiotherapy versus surgery for early-stage non-small cell lung cancer: an updated meta-analysis involving 29,511 patients included in comparative studies
- Stereotactic radiosurgery for brain metastases from small cell lung cancer without prior whole-brain radiotherapy: a meta-analysis
- Meta-analysis of elective pelvic nodal irradiation using moderate hypofractionation for high-risk prostate cancer
- Eficácia e segurança da betaterapia adjuvante pós-ressecção de pterígio: ensaio clínico randomizado com metanálise
- Sequential or concomitant chemotherapy with hypofractionated radiotherapy for locally advanced non-small cell lung cancer: a meta-analysis of randomized trials
- Stereotactic body radiotherapy for prostate cancer: where, when, and who? A bibliometric analysis
- Stereotactic body radiotherapy to treat breast cancer oligometastases: a systematic review with meta-analysis
- Effectiveness and safety of reirradiation with stereotactic ablative radiotherapy of lung cancer after a first course of thoracic radiation: a meta-analysis
- Sobrevida e fatores prognósticos para o câncer de colo do útero tratados por diferentes modalidades
Informações sobre o DOI: 10.1016/j.radonc.2022.09.017 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003257306.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
